Another French Study Looks Into The Use of Nicotine Against Covid-19
1–10 of 56 posts
Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#2Not to be macabre, but could it potentially be that more smokers die before reaching the older age range of most COVID hospitalizations?
Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#3> The researchers will administer nicotine patches to some of the participants for a period of 4 to 5 months, and then carry out a follow-up for 6 to 7 months. Of course, it is still too early to conclude exactly how nicotine interacts with the coronavirus. However, if nicotine is indeed confirmed as a protective factor, NRTs including e-cigarettes could play a pivotal role in controlling this pandemic.
Very curious to see how this goes. I would also love to see information as to why nicotine works this way, and if there are any non-nicotine options that have similar effects? Interesting stuff none the less.
Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#4> The daily smokers rate amongst COVID-19 patients was at 5.3%, whilst amongst the general population, the daily smokers rate was at 25.4%. Not to be macabre, but could it potentially be that more smokers die before reaching the older age range of most COVID hospitalizations?
> The researchers had estimated the rates of daily current smokers among COVID-19-infected patients and compared them to the rates of daily current smokers within the general French population, after controlling the data for sex and age.
So, assuming they correctly controlled for age, then no, it’s not “anti-survivorship” bias. (“Casualty bias”?)
Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#5> The daily smokers rate amongst COVID-19 patients was at 5.3%, whilst amongst the general population, the daily smokers rate was at 25.4%. Not to be macabre, but could it potentially be that more smokers die before reaching the older age range of most COVID hospitalizations?
The first paragraph says: > The researchers had estimated the rates of daily current smokers among COVID-19-infected patients and compared them to the rates of daily current smokers within the general French population, after controlling the data for sex and age. So, assuming they correctly controlled for age, then no, it’s not “anti-survivorship” bias. (“Casualty bias”?)
Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#6Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#7> The study in question will be randomized, national and multi-center, carried out double-blind, and should involve teams from Assistance Publique – Hôpitaux de Paris, Sorbonne University and Inserm. It is expected to include approximately 1,633 medical and non-medical caregivers, working in a health establishment, non-smokers (or former smokers who have quit smoking for more than 12 months), without a history of inf…
I didn’t see something that was a clear consensus, but it seemed like nicotine decidedly modulates the immune system. It seems whatever effects it has might do good things for covid.
Nicotine isn’t evil, and even not particularly addictive when not delivered via burning leaves. (components in smoke change how much enters the brain)
Re: Another French Study Looks Into The Use of Nicotine Against Covid-19
#8> The study in question will be randomized, national and multi-center, carried out double-blind, and should involve teams from Assistance Publique – Hôpitaux de Paris, Sorbonne University and Inserm. It is expected to include approximately 1,633 medical and non-medical caregivers, working in a health establishment, non-smokers (or former smokers who have quit smoking for more than 12 months), without a history of inf…